StockData
Ingevity Corp logo

Ingevity Corp (NGVT) stock

NGVTNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3076% above fair value
$58.31−0.97 (-1.64%)

Close on Nov 18, 2026Market cap $2.00BP/E 39.7Yield –

Ingevity revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Ingevity's revenue for the twelve months ending Jun 30, 2026 was $1.16B, down 1.4% year over year. For fiscal 2025 it was $1.17B, down 2.7% from the year before. Over ten years it grew 2.0% a year on average. The highest annual figure on record is $1.67B in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.17B-2.7%
FY2024Dec 31, 2024$1.20B-1.3%
FY2023Dec 31, 2023$1.22B-27.1%
FY2022Dec 31, 2022$1.67B+19.9%
FY2021Dec 31, 2021$1.39B+14.4%
FY2020Dec 31, 2020$1.22B-5.9%
FY2019Dec 31, 2019$1.29B+14.1%
FY2018Dec 31, 2018$1.13B+16.6%
FY2017Dec 31, 2017$972.40M+7.1%
FY2016Dec 31, 2016$908.30M-5.2%
FY2015Dec 31, 2015$958.30M-7.5%
FY2014Dec 31, 2014$1.04B–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$314.10M-5.2%
Q1 FY2026Mar 31, 2026$258.00M+4.1%
Q4 FY2025Dec 31, 2025$255.10M-3.1%
Q3 FY2025Sep 30, 2025$333.10M-0.2%
Q2 FY2025Jun 30, 2025$331.50M-15.1%
Q1 FY2025Mar 31, 2025$247.90M-27.1%
Q4 FY2024Dec 31, 2024$263.30M-29.2%
Q3 FY2024Sep 30, 2024$333.80M-25.2%
Q2 FY2024Jun 30, 2024$390.60M-18.9%
Q1 FY2024Mar 31, 2024$340.10M-13.4%
Q4 FY2023Dec 31, 2023$371.70M-3.1%
Q3 FY2023Sep 30, 2023$446.00M-7.5%
Q2 FY2023Jun 30, 2023$481.80M+14.7%
Q1 FY2023Mar 31, 2023$392.60M+2.6%
Q4 FY2022Dec 31, 2022$383.60M+14.2%
Q3 FY2022Sep 30, 2022$482.00M+27.9%
Q2 FY2022Jun 30, 2022$419.90M+17.2%
Q1 FY2022Mar 31, 2022$382.80M+19.5%
Q4 FY2021Dec 31, 2021$336.00M+3.2%
Q3 FY2021Sep 30, 2021$376.80M+13.6%
Q2 FY2021Jun 30, 2021$358.40M+32.4%
Q1 FY2021Mar 31, 2021$320.30M+11.1%
Q4 FY2020Dec 31, 2020$325.60M+7.3%
Q3 FY2020Sep 30, 2020$331.70M-7.8%
Q2 FY2020Jun 30, 2020$270.60M-23.3%
Q1 FY2020Mar 31, 2020$288.20M+4.1%
Q4 FY2019Dec 31, 2019$303.40M+8.9%
Q3 FY2019Sep 30, 2019$359.90M+15.6%
Q2 FY2019Jun 30, 2019$352.80M+14.3%
Q1 FY2019Mar 31, 2019$276.80M+17.7%
Q4 FY2018Dec 31, 2018$278.60M+21.4%
Q3 FY2018Sep 30, 2018$311.20M+17.8%
Q2 FY2018Jun 30, 2018$308.60M+18.6%
Q1 FY2018Mar 31, 2018$235.20M+7.6%
Q4 FY2017Dec 31, 2017$229.50M+8.8%
Q3 FY2017Sep 30, 2017$264.10M+4.6%
Q2 FY2017Jun 30, 2017$260.30M–
Q1 FY2017Mar 31, 2017$218.50M–
Q4 FY2016Dec 31, 2016$210.90M–
Q3 FY2016Sep 30, 2016$252.40M–

More Ingevity figures

See a number that looks wrong?